OOIR: Observatory of International Research

Papers

(The TQCC of Journal of Clinical Apheresis is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)

Article	Citations
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Ninth Special Issue	162
Direct hemoperfusion using a polymyxin B‐immobilized polystyrene column for COVID‐19	29
Ninety days transplant free survival with high volume plasma exchange in Wilson disease presenting as acute liver failure	24
Efficacy of convalescent plasma therapy for COVID‐19: A systematic review and meta‐analysis	19
Rapid reduction in triglyceride levels by therapeutic plasma exchange in patients with hypertriglyceridemic pancreatitis	18
Refractory vaccine‐induced immune thrombotic thrombocytopenia (VITT) managed with delayed therapeutic plasma exchange (TPE)	18
Effect of TPE vs medical management on patient outcomes in the setting of hypertriglyceridemia‐induced acute pancreatitis with severely elevated triglycerides	16
Immunoadsorption and plasma exchange—Efficient treatment options for neurological autoimmune diseases	14
The use of therapeutic plasma exchange as adjunctive therapy in the treatment of coronavirus disease 2019: A critical appraisal of the current evidence	14
A matched cohort study of convalescent plasma therapy for COVID‐19	13
Immune checkpoint inhibitor toxicity: A new indication for therapeutic plasma exchange?	12
Plasmapheresis compared with conventional treatment for hypertriglyceridemia‐induced acute pancreatitis: A systematic review and meta‐analysis	11
Initial experience with high‐volume plasma exchange in patients with acute liver failure	10
Special Issue Abstracts from the American Society for Apheresis 44th Annual Meeting April 26–28, 2023	10
Biomarker profile predicts clinical efficacy of extracorporeal photopheresis in steroid‐resistant acute and chronic graft‐vs‐host disease after allogenic hematopoietic stem cell transplant	10
Incidence, diagnosis, and outcome of immune‐mediated thrombotic thrombocytopenic purpura: A nationwide survey by the Spanish registry of thrombotic thrombocytopenic purpura	10
Parasite burden and red blood cell exchange transfusion for babesiosis	9
Efficacy of therapeutic plasma exchange in patients with Crimean‐Congo hemorrhagic fever	9
“Plasma exchange in a bottle”: An overview of efgartigimod for apheresis practitioners	9
Therapeutic plasma‐exchange improves short‐term, but not long‐term, outcomes in patients with acute‐on‐chronic liver failure: A propensity score‐matched analysis	9
Therapeutic plasma exchange and dextran‐sulfate plasma adsorption as extracorporeal treatments of extremely preterm preeclampsia with fetal growth restriction	9
Therapeutic plasma exchange is a safe and effective bridge therapy in patients with alcohol‐associated ACLF not having immediate prospects for liver transplantation—A case‐control, pilot st	8
Peptide GAM immunoadsorption in anti‐PLA₂R positive autoimmune membranous nephropathy. The PRISM trial	8
Hemostatic effects of therapeutic plasma exchange: A concise review	8
Therapeutic plasma exchange in patients with sepsis: Secondary analysis of a cluster‐randomized controlled trial	7

Neonatal Fc receptor blockade as emerging therapy in diseases with plasma exchange indications	7
Tolerance and complications of therapeutic plasma exchange by centrifugation: A single center experience	7
Therapeutic plasma exchange for the treatment of refractory necrotizing autoimmune myopathy	7
Pediatric double positive anti‐glomerular basement membrane antibody and anti‐neutrophil cytoplasmic antibody glomerulonephritis—A case report with review of literature	7
Lack of defined apheresis collection criteria in publicly available CAR‐T cell clinical trial descriptions: Comprehensive review of over 600 studies	7
Stem cell mobilization in multiple myeloma patients relapsing after previous autologous hematopoietic stem cell transplantation: A multicenter report by the Polish Myeloma Study Group	7
Abstract	7
Therapeutic plasma exchange with albumin as a valuable method of preparing thyrotoxic patients for a life‐saving thyroidectomy	7
Peripheral blood stem cell collection in children with extremely low body weight (≤8 kg). What have we learned over the past 25 years and where are the limits?	7
Source plasma deferral trends: A 3‐year analysis of 255 centers in the United States	6
The first pediatric case of hemophagocytic lymphohistiocytosis secondary to Crimean‐Congo haemorrhagic fever successfully treated with therapeutic plasma exchange accompanying ribavirin and	6
Role of extracorporeal photopheresis in the management of children with graft‐vs‐host disease	6
Comparison of three modalities of plasmapheresis on coagulation: Centrifugal, single‐membrane filtration, and double‐filtration plasmapheresis	6
Treatment of refractory myasthenia gravis by double‐filtration plasmapheresis and rituximab: A case series of nine patients and literature review	6
Double filtration plasmapheresis in hypertriglyceridemic pancreatitis: Triglyceride levels and clinical outcomes	6
Assessing efficacy and safety of replacement fluids in therapeutic plasma exchange: A systematic scoping review of outcome measures used	5
Analysis of laboratory parameters for optimal autologous peripheral blood stem cell collection from lymphoma and myeloma patients	5
Comparison of centrifugal and membrane filtration modalities on therapeutic plasma exchange	5
Therapeutic plasma exchange for peripheral neuropathy associated with trisulfated heparan disaccharide IgM antibodies: A case series of 17 patients	5
Cardiovascular events in patients with familial hypercholesterolemia and hyperlipoproteinaemia (a): Indications for lipoprotein apheresis in Poland	5
Ultrasound‐based criteria for adequate peripheral venous access in therapeutic apheresis procedures	5
Novel use of a midline catheter for therapeutic and donor apheresis in children and adults	5
Patients with hereditary hemochromatosis reach safe range of transferrin saturation sooner with erythrocytaphereses than with phlebotomies	5
Description of parallel and sequential configurations for concurrent therapeutic plasma exchange and continuous kidney replacement therapy in adults	5
Immunogenic and immunotolerogenic effects of extracorporeal photopheresis in high immunological risk kidney recipients. A single center case series	5
Outcome of desensitization in human leukocyte antigen and ABO incompatible living donor kidney transplantation: Single center experience of first 200 incompatible transplants	5
Therapeutic plasma exchange for steroid refractory idiopathic inflammatory myopathies with interstitial lung disease	4
Rheopheresis for severe peripheral arterial disease in hemodialysis patients: A clinical series	4
Exogenous insulin antibody syndrome treated with plasma exchange after an incomplete response to immunosuppressive therapy	4
Use of therapeutic plasma exchange in heparin‐induced thrombocytopenia: A population‐based study	4
Analysis of 52 240 source plasma donors of convalescent COVID‐19 plasma: Sex, ethnicity, and age association with initial antibody levels and rate of dissipation	4
Severe complications in a 25‐year‐old male after brown recluse spider bite treated by therapeutic plasma exchange: A case report and review of other case studies	4
Early is superior to late plasma exchange for severe multisystem inflammatory syndrome in children	4
Application of the French TMA Reference Center Score and the mortality in TTP Score in de novo and relapsed episodes of acquired thrombotic thrombocytopenic purpura at	4
Concomitant pharmacologic medications influence the clinical outcomes of granulocyte and monocyte adsorptive apheresis in patients with ulcerative colitis: A multicenter retrospective cohort study	4
Apheresis medicine in the era of advanced telehealth technologies: An American Society for Apheresis position paper part II: Principles of apheresis medical practice in a 21st century electronic medic	4
Therapeutic plasmapheresis for the treatment of thyrotoxicosis: A retrospective multi‐center study	4
Correlation between peripheral blood automated hematopoietic progenitor cell counts and flow cytometric CD34⁺ cell counts differs according to diagnosis in patients undergoing au	4
Isoagglutinin removal by plasma centrifugation or filtration (single or double): A prospective study in a single center	4
Membrane‐based therapeutic plasma exchange: Hemodynamics and operational characteristics leading to procedure failure	4
Clinical experience with maintenance therapeutic plasma exchange in refractory generalized myasthenia gravis	4
Efficacy of peripheral arterial access for peripheral blood stem cells collection	4
Outcome of extracorporeal photopheresis in mycosis fungoides patients is not predicted by quotients of systemic immune‐inflammatory biomarkers	3
Treatment of comatose patient from cyclobenzaprine overdose with therapeutic plasma exchange	3
The impact of delayed and immediate adverse events on the intention of future donations in whole blood and plateletpheresis donors	3
Early response to caplacizumab and rituximab after anaphylaxis to Octaplas plasma in a patient with thrombotic thrombocytopenic purpura	3
Further evidence for the benefit of therapeutic plasma exchange for acute multi‐organ failure syndrome refractory to red cell exchange in sickle cell disease	3
Safe peripheral blood stem cell collection in patients less than 10 kg: A single‐center review	3
A case of severe DRESS syndrome treated with therapeutic plasma exchange and intravenous immunoglobulin therapy	3
Nationwide practices in the use of central venous catheters for therapeutic plasma exchange in the inpatient setting	3

Addition of plerixafor in poorly mobilized allogeneic stem cell donors	3
Therapeutic plasma exchange: A potential therapeutic modality for critically ill adults with severe acute respiratory syndrome coronavirus 2 infection	3
Efficacy of plasmapheresis and semi‐selective immunoadsorption for removal of anti‐HLA antibodies	3
The role of treatment with plasma exchange therapy in two pediatric toxic epidermal necrolysis cases related to COVID‐19	3
Is absence of CD56 a predictive factor for peripheral blood stem cell mobilization failure in patients with multiple myeloma?	3
Plerixafor added to G‐CSF allows mobilization of a sufficient number of hematopoietic progenitors without impacting the efficacy of TCR‐alpha/beta depletion in pediatric haploide	3
Impact of the number of cryopreserved CD34⁺ cells in the infused blood grafts on hematologic recovery and survival in myeloma patients after autologous stem cell transplantation:	3
Treatment of antibody‐mediated rejection with double‐filtration plasmapheresis, low dose IVIg plus rituximab after kidney transplantation	3
Hematopoietic progenitor cell counting can optimize peripheral blood stem cell apheresis process	3
Autologous hematopoietic stem cell product contaminated with Salmonella due to occult salmonellosis in an asymptomatic donor	3
Fibrinogen reconstitution after therapeutic apheresis: Comparison of double‐filtration plasmapheresis, plasma exchange, and immunoadsorption	3
Race/ethnicity and underlying disease influences hematopoietic stem/progenitor cell mobilization response: A single center experience	3
Positive effects of ultrasound‐guided peripheral IV insertion on pediatric sickle cell anemia/thalassemia patients receiving automated red cell exchange procedures or chronic tra	3
Efficacy of intravenous combined immunosuppression with plasmapheresis in adult patients with refractory primary focal segmental glomerulosclerosis	3
Adsorptive granulomonocytapheresis alters the gut bacterial microbiota in patients with active ulcerative colitis	3
Cost saving, patient centered algorithm for progenitor cell mobilization for autologous hematopoietic cell transplantation	3
Infectious risks in patients treated with extracorporeal photopheresis for graft‐versus‐host disease: A retrospective cohort study	3
Mobilized and apheresis‐collected endothelial progenitor cells with plerixafor	3